168 related articles for article (PubMed ID: 21732214)
1. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.
Sookwong P; Nakagawa K; Fujita I; Shoji N; Miyazawa T
Lipids; 2011 Oct; 46(10):943-52. PubMed ID: 21732214
[TBL] [Abstract][Full Text] [Related]
2. Tandem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():280-3. PubMed ID: 16037249
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of blood lipid glycation and lipid oxidation in diabetic patients.
Suzuki K; Nakagawa K; Miyazawa T
Clin Chem Lab Med; 2014 Jan; 52(1):47-52. PubMed ID: 23454716
[TBL] [Abstract][Full Text] [Related]
4. Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor.
Higuchi O; Nakagawa K; Tsuzuki T; Suzuki T; Oikawa S; Miyazawa T
J Lipid Res; 2006 May; 47(5):964-74. PubMed ID: 16470027
[TBL] [Abstract][Full Text] [Related]
5. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
[TBL] [Abstract][Full Text] [Related]
6. Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes.
Nakagawa K; Oak JH; Higuchi O; Tsuzuki T; Oikawa S; Otani H; Mune M; Cai H; Miyazawa T
J Lipid Res; 2005 Nov; 46(11):2514-24. PubMed ID: 16150834
[TBL] [Abstract][Full Text] [Related]
7. Evidence of a glycemic threshold for the development of cataracts in diabetic rats.
Swamy-Mruthinti S; Shaw SM; Zhao HR; Green K; Abraham EC
Curr Eye Res; 1999 Jun; 18(6):423-9. PubMed ID: 10435829
[TBL] [Abstract][Full Text] [Related]
8. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.
Shoji N; Nakagawa K; Asai A; Fujita I; Hashiura A; Nakajima Y; Oikawa S; Miyazawa T
J Lipid Res; 2010 Aug; 51(8):2445-53. PubMed ID: 20386060
[TBL] [Abstract][Full Text] [Related]
9. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples.
Oak JH; Nakagawa K; Miyazawa T
J Lipid Res; 2002 Mar; 43(3):523-9. PubMed ID: 11893788
[TBL] [Abstract][Full Text] [Related]
10. A convenient method for preparation of high-purity, Amadori-glycated phosphatidylethanolamine and its prooxidant effect.
Miyazawa T; Oak JH; Nakagawa K
Ann N Y Acad Sci; 2005 Jun; 1043():276-9. PubMed ID: 16037248
[TBL] [Abstract][Full Text] [Related]
11. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage.
Meng J; Sakata N; Takebayashi S; Asano T; Futata T; Nagai R; Ikeda K; Horiuchi S; Myint T; Taniguchi N
Atherosclerosis; 1998 Feb; 136(2):355-65. PubMed ID: 9543107
[TBL] [Abstract][Full Text] [Related]
12. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes--influence of glycation products on lipid peroxidation.
Breitling-Utzmann CM; Unger A; Friedl DA; Lederer MO
Arch Biochem Biophys; 2001 Jul; 391(2):245-54. PubMed ID: 11437356
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Identification of Amadori Compound-Modified Phosphatidylethanolamines in Human Plasma.
He X; Chen GY; Zhang Q
Chem Res Toxicol; 2019 Jul; 32(7):1449-1457. PubMed ID: 31188577
[TBL] [Abstract][Full Text] [Related]
14. Lipid glycation and protein glycation in diabetes and atherosclerosis.
Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
[TBL] [Abstract][Full Text] [Related]
15. A UPLC-MRM-MS method for comprehensive profiling of Amadori compound-modified phosphatidylethanolamines in human plasma.
He X; Li Z; Zhang Q
Anal Bioanal Chem; 2021 Jan; 413(2):431-443. PubMed ID: 33111151
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic potency of Amadori-glycated phosphatidylethanolamine.
Nakagawa K; Oak JH; Miyazawa T
Ann N Y Acad Sci; 2005 Jun; 1043():413-6. PubMed ID: 16037263
[TBL] [Abstract][Full Text] [Related]
17. Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions.
Oak J; Nakagawa K; Miyazawa T
FEBS Lett; 2000 Sep; 481(1):26-30. PubMed ID: 10984609
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat.
Perez Gutierrez RM; de Jesus Martinez Ortiz M
Pharm Biol; 2014 Nov; 52(11):1435-44. PubMed ID: 25026338
[TBL] [Abstract][Full Text] [Related]
19. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.
Oak JH; Nakagawa K; Oikawa S; Miyazawa T
FEBS Lett; 2003 Dec; 555(2):419-23. PubMed ID: 14644453
[TBL] [Abstract][Full Text] [Related]
20. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
Ansari NA; Moinuddin ; Alam K; Ali A
Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
